HEALTH TIPS.: Smoked cannabis as an adjunctive second-line therapy to treat chronic peripheral neuropathy can be both effective and cost-effective, suggests a new study that used a computer simulation model to simulate its use in one million patients.

Wednesday, 30 January 2019

Smoked cannabis as an adjunctive second-line therapy to treat chronic peripheral neuropathy can be both effective and cost-effective, suggests a new study that used a computer simulation model to simulate its use in one million patients.

Smoked cannabis as an adjunctive second-line therapy to treat chronic peripheral neuropathy can be both effective and cost-effective, suggests a new study that used a computer simulation model to simulate its use in one million patients.

submitted by /u/mvea
[link] [comments]

from Health http://bit.ly/2HE9Y9p
via IFTTT

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)